Cargando…
Neuropharmacological Treatment of Mental Dysfunction in Parkinson’s Disease
Many patients with Parkinson's Disease (PD) experience significant cognitive and mood impairment -even early in the course of the disease. These mental impairments are only partially responsive to levodopa treatment and are often as disabling as the motor impairment, particularly in mid and lat...
Autores principales: | McNamara, Patrick, Durso, Raymon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471533/ https://www.ncbi.nlm.nih.gov/pubmed/16720959 http://dx.doi.org/10.1155/2006/138263 |
Ejemplares similares
-
Religiosity in patients with Parkinson’s disease
por: McNamara, Patrick, et al.
Publicado: (2006) -
Side of Onset in Parkinson’s Disease and Alterations in Religiosity: Novel Behavioral Phenotypes
por: Butler, Paul M., et al.
Publicado: (2011) -
The Impact of Clinical and Cognitive Variables on Social Functioning in Parkinson's Disease: Patient versus Examiner Estimates
por: McNamara, Patrick, et al.
Publicado: (2010) -
Neuropharmacologic Approaches to Cognitive Rehabilitation
por: Klein, Reva, et al.
Publicado: (2006) -
Neuropharmacology
por: Rosner, Burton S.
Publicado: (1956)